Indefinite Delivery Contract 36C25221D0074
Award Date
9/30/21
Last Date to Order
9/29/25
Federal Agency
Veterans Integrated Service Network 12
Awardee
Caredx, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV was awarded by the Department of Veterans Affairs, Network Contracting Office 23 to Caredx, Inc., a for-profit organization headquartered in Brisbane, California. The single-award, $724,391.25 Indefinite Delivery Contract is for AlloSure in-home patient testing services, which are used to assess organ rejection risks in transplant recipients. The contract covers a range of specialized genetic and molecular testing services, including AlloMap and AlloSure testing kits, as...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 17 awarded a single-award indefinite delivery contract to Caredx Lab Solutions Inc., a subsidiary of Caredx Inc., to provide AlloMap molecular testing services for heart transplant recipients. The $675,000 IDC, which runs through June 2027 with no set-aside, establishes Caredx as the sole supplier of the FDA-approved AlloMap test to aid in post-transplant surveillance and...
The federal contract IDV award is for LAB TESTS FOR POST TRANSPLANT CARE, issued by the Department of Veterans Affairs (VA) to the prime contractor Caredx, Inc., a for-profit medical diagnostics company based in Brisbane, California. This is a single-award Indefinite Delivery Contract valued at $4,367,680.42 with a period of performance from April 1, 2025 to March 31, 2030. The contract aims to procure a range of specialized genetic and molecular testing services from Caredx, including the...
This federal Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit medical technology company specializing in advanced diagnostic solutions for organ transplant patients. The $2,161,369.44 IDC, which is not set aside, enables the VA to issue multiple task orders for Caredx's specialized genetic and molecular testing services to support post-transplant patient care and monitoring across the VA's Veterans Integrated Service...
The key products and services being delivered under this federal contract IDV award are specialized renal transplant histocompatibility testing services. The prime contractor, Loyola University Health System, is a nonprofit healthcare provider in Chicago, Illinois, and the only University HealthSystem Consortium (UNOS)-approved laboratory in the state capable of performing these critical tests. The Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 12 (VISN...
The Department of Veterans Affairs Veterans Health Administration (VHA) awarded a single-award indefinite delivery contract (IDC) to Karius, Inc., a life sciences company specializing in diagnostic testing, to provide next-generation sequencing tests at $2,000 per test. The $600,000 IDC, with an ultimate completion date of July 31, 2027, was awarded on August 22, 2022 to Karius as the sole responsible source capable of meeting the VHA's requirements. Two task orders have been issued against this...
The Department of Veterans Affairs (VA), Veterans Health Administration, Network Contracting Office 17, has awarded a firm-fixed-price Indefinite Delivery Contract (IDC) to Karius, Inc., a life sciences company specializing in diagnostic services for infectious diseases. The IDC, valued at $600,000 and effective through July 31, 2027, allows the VA to purchase next-generation sequencing (NGS) tests from Karius at $2,000 per test. Karius has been identified as the sole responsible source...
The U.S. Department of Veterans Affairs (VA) has awarded a multiple-award Federal Supply Schedule (FSS) contract under the Medical Laboratory Testing and Analysis Services GSA Schedule (FSS-621-II) to Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation. This IDV contract, valued at $2,260,562, provides the VA with access to Exosome Diagnostics' non-invasive, urine-based liquid biopsy test, the ExoDx Prostate (IntelliScore), which analyzes exosomal RNA biomarkers to assess the risk...
The Department of Veterans Affairs (VA) has awarded Cepheid, a for-profit manufacturer of molecular diagnostic solutions, an Indefinite Delivery Contract (IDC) to provide reagents, test kits, and associated maintenance and support services to support the VA's clinical testing programs serving veterans. The contract, valued at up to $532,310.79, is a single-award IDC with the VA's Veterans Integrated Service Network 16 and does not have any set-aside designations. Under this IDC, the VA has...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a single-award indefinite delivery contract (IDC) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $3.4 million, 5-year IDC is for the provision of Cepheid test kits compatible with the VA's existing GeneXpert analyzers, including tests for COVID-19, influenza, and respiratory syncytial virus. The contract has no set-aside designation. Under the initial $579,360 firm fixed-price...
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 36C25221D0074-36C25225N0010 | Caredx, Inc. | $2.4m | 10/1/24 | 9/30/25 | 10/1/24 | |
Delivery Order 36C25221D0074-36C25223N0037 | Caredx, Inc. | $676.1k | 1/1/23 | 9/30/23 | 12/12/23 | |
Delivery Order 36C25221D0074-36C25222N0635 | Caredx, Inc. | $363.6k | 9/30/22 | 9/29/23 | 9/29/22 | |
Delivery Order 36C25221D0074-36C25221N0645 | Caredx, Inc. | $1.6m | 9/30/21 | 12/16/22 | 12/16/22 | |
Delivery Order 36C25221D0074-36C25223N0621 | Caredx, Inc. | $2.0m | 9/30/23 | 9/29/24 | 7/8/24 |